| Literature DB >> 31631001 |
Jacob A Torres1, Samantha L Kruger1, Caroline Broderick1, Tselmeg Amarlkhagva1, Shagun Agrawal1, John R Dodam2, Michal Mrug3, Leslie A Lyons2, Thomas Weimbs4.
Abstract
Mild reduction in food intake was recently shown to slow polycystic kidney disease (PKD) progression in mouse models, but whether the effect was due to solely reduced calories or some other aspect of the diet has been unclear. We now show that the benefit is due to the induction of ketosis. Time-restricted feeding, without caloric reduction, strongly inhibits mTOR signaling, proliferation, and fibrosis in the affected kidneys in a PKD rat model. A ketogenic diet had a similar effect and led to regression of renal cystic burden. Acute fasting in rat, mouse, and feline models of PKD results in rapid reduction of cyst volume, while oral administration of the ketone β-hydroxybutyrate (BHB) in rats strongly inhibits PKD progression. These results suggest that cystic cells in PKD are metabolically inflexible, which could be exploited by dietary interventions or supplementation with BHB, representing a new therapeutic avenue to treat PKD.Entities:
Keywords: beta-hydroxybutyrate; ketogenic diet; ketosis; metabolic inflexibility; polycystic kidney disease
Mesh:
Substances:
Year: 2019 PMID: 31631001 PMCID: PMC6904245 DOI: 10.1016/j.cmet.2019.09.012
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287